Cell ReportsCell BiologyPeer-reviewed journal article
Topoisomerase 3A (TOP3A) Dependent Alternative Lengthening of Telomeres (ALT)
Prashant KhandagaleiD, Yilun SuniD, Daiki TaniyamaiD, Sourav Taru Saha, Liton Kumar SahaiD, Yves G. PommieriD
Abstract
Alternative Lengthening of Telomeres (ALT) is a homologous recombination-dependent telomere elongation mechanism utilized by at least 10-15% of all cancers. Here we identified that the DNA topoisomerase, TOP3A is enriched at the telomeres of ALT cells but not at the telomeres of telomerase-positive (Tel) cancer cells. We demonstrate that TOP3A stabilizes the shelterin protein TERF2 in ALT cancer cell lines but not in Tel cells and that long non-coding telomere transcribed RNA (TERRA) enrichment at telomeres depends upon TOP3A. TOP3A also promotes the generation of single-stranded telomeric C-strand (ssTeloC) DNA, which is a recently discovered marker for ALT. Additionally, we found that inducing TOP3A-DNA-protein crosslinks in ALT cells suppresses TERRA enrichment as well as destabilizes TERF2. Taken together these observations uncover the unexplored functions of TOP3A at ALT telomeres and suggest the potential of developing an ALT-specific cancer therapeutic strategy targeting TOP3A.
- organism: human
- research focus: host-pathogen & immune response
- research focus: cancer & tumor microenvironment
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
- Citations
- 9
- FWCI
- 5.05
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Conserved and Unique Features of Terminal Telomeric Sequences in ALT-Positive Cancer Cells
Benura Azeroglu, Wei Wu, … Eros Lazzerini Denchi·eLifePeer-reviewed·Aug 1, 2025
- TERRA transcription destabilizes telomere integrity to initiate break-induced replication in human ALT cells.
B. Silva, R. Arora, C. M. Azzalin·bioRxiv·Feb 18, 2021
- METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma
R. Vaid, K. Thombare, … T. Mondal·Nucleic Acids ResearchPeer-reviewed·Mar 21, 2024
- Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres
T. K. Loe, J. Li, … E. Lazzerini Denchi·bioRxiv·Feb 7, 2020
- Cancer cells with alternative lengthening of telomeres do not display a general hypersensitivity to ATR inhibition
Katharina I. Deeg, Inn Chung, … Karsten Rippe·bioRxiv·Jun 4, 2016
- Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers
Declan Bennett, Monika Wierdl, … Lillian M. Guenther·bioRxiv·May 28, 2026